Used as a potent and selective inhibitor in biochemical research, particularly targeting kinases involved in cellular signaling pathways. It is employed in studies related to cancer cell proliferation and apoptosis, showing promise in the development of targeted therapies for hematological malignancies. Its structure allows for high binding affinity and improved pharmacokinetic properties, making it suitable for in vitro and in vivo studies. Commonly utilized in drug discovery programs to optimize lead compounds for oncology applications.